시장보고서
상품코드
1832086

안압계 시장 규모, 점유율, 동향, 예측 : 유형별, 기술별, 휴대성별, 최종사용자별, 지역별(2025-2033년)

Tonometer Market Size, Share, Trends and Forecast by Type, Technology, Portability, End User, and Region, 2025-2033

발행일: | 리서치사: IMARC | 페이지 정보: 영문 138 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 안압계 시장 규모는 2024년 3억 7,490만 달러에 달했습니다. 향후 IMARC Group은 이 시장이 2033년까지 5억 5,580만 달러에 달할 것으로 예상하며, 2025년부터 2033년까지 4.5%의 CAGR을 기록할 것으로 예측하고 있습니다. 현재 북미가 시장을 독점하고 있으며, 2024년 시장 점유율은 39.6%를 넘어섰습니다. 이러한 우위는 높은 녹내장 유병률, 선진화된 의료 인프라, 강력한 상환 정책, 디지털 안압계의 보급에 기인합니다. R&D 투자 증가, 인구 고령화, 정기적인 안과 검진이 시장 성장을 더욱 촉진하고 질병의 조기 발견과 치료를 보장하고 있습니다.

세계 안압계 시장은 비접촉식 안압계, 반발식 안압계 등 환자의 편의성과 진단 정확도를 높이는 안압계 기술 발전에 힘입어 성장하고 있습니다. 특히 개발도상국에서는 시력 관리 프로그램에 대한 정부의 노력이 증가하고 있으며, 안압 측정에 대한 접근성이 확대되고 있습니다. 당뇨망막병증, 안압항진증 등 당뇨병 관련 안질환의 증가로 인해 정기적인 안압 모니터링이 필요하게 되었습니다. AI를 통합한 진단 도구에 대한 투자가 증가함에 따라 질병의 조기 발견이 향상되고 있습니다. 신흥국의 헬스케어 인프라 확대와 안과 전문 클리닉의 존재감 증가가 시장 성장에 기여하고 있습니다. 또한, 원격의료 및 원격 안과 검진 서비스의 급격한 증가는 안질환의 조기 및 광범위한 발견을 가능하게함으로써 시장 확대를 촉진하고 있습니다.

미국 안압계 시장은 제품 혁신과 품질 기준을 보장하는 강력한 규제 프레임워크에 힘입어 FDA 승인을 받은 첨단 안압 측정기기의 채택으로 이어지고 있습니다. 젊은 층의 근시 및 원시 유병률이 증가함에 따라 정기적인 안과 검진에 대한 수요가 증가하고 있습니다. 안과 기기 제조업체와 연구기관과의 전략적 제휴를 통해 기술력 강화를 도모하고 있습니다. 휴대용 및 휴대용 안압계의 인기가 높아짐에 따라 재택의료 및 외래 환경에서의 사용이 증가하고 있습니다. 예방적 안과 의료서비스에 대한 보험 적용이 확대되고, 잦은 검진이 권장되고 있습니다. 또한, 주요 안과 기기 제조업체의 존재와 AI 기반 안압 측정 솔루션에 대한 투자 증가로 인해 시장 성장이 가속화되고 있습니다. 예를 들어, 2024년 5월 Reichert Technologies는 자동화된 신뢰할 수 있는 안압(IOP) 측정을 위한 특허 받은 ActiView 시스템을 특징으로 하는 Tono-Vera 안압계를 미국에서 출시했습니다. 이 핸드헬드 장치는 반사식 안압계를 사용하며 마취가 필요하지 않습니다. 사용하기 쉬운 디자인과 블루투스 연결로 골드만 안압계에 버금가는 빠르고 정확한 측정값을 제공합니다. 안과 진단의 선두주자인 라이헬트는 Tono-Vera를 통해 녹내장 환자 치료를 강화하기 위한 기술 혁신을 지속하고 있습니다.

안압계 시장 동향:

토노메트리에 인공지능을 통합하는 방법

안압 측정에 인공지능(AI)을 접목하여 진단 정확도와 환자 관리를 향상시켜 안압 측정에 변화를 가져오고 있습니다. AI가 탑재된 안압계는 머신러닝 알고리즘을 활용하여 대규모 데이터세트를 분석하여 녹내장 및 안구 고혈압을 조기에 발견할 수 있습니다. 이 장치는 기존 방법으로는 놓칠 수 있는 안압의 미세한 변화를 평가할 수 있어 보다 정확한 모니터링이 가능합니다. AI의 통합은 자동 데이터 해석을 지원하여 전문가의 평가에 대한 의존도를 낮추고, 원격지나 소외된 지역에서의 접근성을 향상시킬 수 있습니다. 또한, AI 지원 안압계는 예측 분석을 용이하게 하여 심각한 시력 저하가 발생하기 전에 녹내장 발병 위험이 있는 환자를 식별할 수 있습니다. 맞춤형 의료 및 디지털 건강 솔루션에 대한 관심이 높아지면서 AI 지원 안압계가 더욱 발전하고 환자 결과를 개선하고 있습니다. 예를 들어, 2024년 5월, 탑콘 헬스케어는 마이크로소프트와 협력하여 AI가 주도하는 '눈에서 건강관리' 솔루션을 추진하게 됩니다. 클라우드 플랫폼을 이용하여 안구 스캔을 통한 전신질환 및 신경질환의 사전 스크리닝을 실시합니다. 탑콘의 IDHea는 AI 연구를 촉진하고 데이터 보안을 보장합니다. AI 이노베이터에 투자하고, 안전한 데이터 관리를 위해 Microsoft Azure를 사용하고 있습니다. 이는 AI를 활용한 안과 진단을 통해 헬스케어의 접근성, 품질, 가격의 향상을 목표로 하고 있습니다.

비접촉식 및 휴대용 안압계의 부상

비접촉식 안압계와 휴대용 안압계의 채택이 증가하고 있으며, 환자의 편안함과 편의성을 높여 시장을 형성하고 있습니다. 비접촉식 안압계(에어퍼프 안압계)는 마취의 필요성을 없애고, 불편함과 교차 오염의 위험을 줄입니다. 이 장치는 기존의 안압 측정 기술에 민감한 소아 및 노년층 환자에게 특히 유용합니다. 예를 들어, 2023년 4월, Nidek은 시장의 요구에 부응하기 위해 파치메트리를 생략한 NT-1/1e 비접촉식 안압계를 출시하였습니다. NT-1은 환자 안전 기능과 음성 안내를 통한 자동 안압 측정 기능을 제공합니다. NT-1e는 3D 트래킹을 통한 수동 측정이 가능합니다. 두 모델 모두 클리닉의 효율성과 환자의 편안함을 향상시키기 위해 유연하고 공간 절약형 디자인을 채택했습니다. 이와 함께 휴대용 안압계와 휴대용 안압계는 재택의료 환경, 외래 센터 및 원격 안과 서비스에서 인기를 얻고 있으며, 원격 모니터링을 가능하게하고 빈번한 임상 방문의 필요성을 줄이고 있습니다. 안압계의 소형화는 무선 연결 및 클라우드 기반 데이터 저장과 결합하여 의료 제공자와 환자 간의 실시간 데이터 공유를 가능하게 하고, 지속적인 안압 모니터링과 고위험군에 대한 적시 개입을 촉진합니다.

원격 안과 의료와 원격 안과 의료 서비스의 확대

원격 안과 및 원격 안과 의료 솔루션에 대한 수요 증가는 안압계 시장에 큰 영향을 미치고 있습니다. 접근성이 높고 비용 효율적인 안과 의료에 대한 관심이 높아지면서 많은 의료 서비스 제공자가 디지털 건강 플랫폼에 안압 측정을 통합하고 있습니다. 연결된 안압 측정 장치와 원격의료 애플리케이션을 통한 원격 안압 측정은 안과 의사가 환자를 자주 대면하지 않고도 환자를 모니터링할 수 있게 해줍니다. 이러한 추세는 전문 안과 의료에 대한 접근성이 제한되어 있는 농촌 지역이나 의료 서비스가 충분하지 않은 지역에서 특히 큰 영향력을 발휘합니다. 또한, 안압을 지속적으로 모니터링할 수 있는 웨어러블 안압계가 확대되면서 질병의 조기 발견이 강화되고 있습니다. 예를 들어, 2024년 3월, 국립 안과 연구소는 혁신적인 스마트 콘택트렌즈 안압계를 개발하기 위해 퍼듀 대학에 670만 달러를 지원했습니다. 'StickTronics'를 활용한 이 특허 출원 중인 장치는 안압(IOP)을 지속적으로 모니터링하고 치료제를 투여함으로써 녹내장과 같은 만성 안질환 관리를 돕습니다. 이 외에도 가상 안과 검진 및 AI를 활용한 진단으로의 전환은 녹내장 관리의 격차를 해소하고 적시에 개입하여 시력 장애의 위험을 줄일 수 있을 것으로 기대됩니다.

목차

제1장 서문

제2장 조사 범위와 조사 방법

  • 조사 목적
  • 이해관계자
  • 데이터 소스
    • 1차 정보
    • 2차 정보
  • 시장 추정
    • 상향식 접근
    • 하향식 접근
  • 조사 방법

제3장 주요 요약

제4장 소개

제5장 세계의 안압계 시장

  • 시장 개요
  • 시장 실적
  • COVID-19의 영향
  • 시장 예측

제6장 시장 내역 : 유형별

  • 직접
  • 간접

제7장 시장 내역 : 기술별

  • 압평 안압 측정법
  • 인덴테이션 안압 측정
  • 리바운드 안압 측정
  • 기타

제8장 시장 내역 : 휴대성별

  • 데스크톱
  • 핸드헬드

제9장 시장 내역 : 최종사용자별

  • 병원
  • 안과

제10장 시장 내역 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 인도네시아
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 러시아
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타
  • 중동 및 아프리카

제11장 SWOT 분석

제12장 밸류체인 분석

제13장 Porter's Five Forces 분석

제14장 가격 분석

제15장 경쟁 구도

  • 시장 구조
  • 주요 기업
  • 주요 기업 개요
    • 66 Vision Tech Co. Ltd.(Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.)
    • AMETEK Inc.
    • Canon Inc.
    • Haag-Streit Group(Metall Zug AG)
    • Keeler Ltd.(Halma plc)
    • Kowa American Corporation(Kowa Company Limited)
    • Nidek Co. Ltd.
    • Revenio Group Oyj
    • Rexxam Co. Ltd.
    • Tomey Corporation
    • Topcon Corporation
    • Ziemer Ophthalmic Systems AG
KSM 25.10.17

The global tonometer market size was valued at USD 374.9 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 555.8 Million by 2033, exhibiting a CAGR of 4.5% from 2025-2033. North America currently dominates the market, holding a market share of over 39.6% in 2024. This dominance can be attributed to high glaucoma prevalence, advanced healthcare infrastructure, strong reimbursement policies, and widespread adoption of digital tonometers. Increased R&D investments, aging population, and regular eye screenings further drive market growth, ensuring early disease detection and treatment.

The global tonometer market is driven by technological advancements in tonometry, including non-contact and rebound tonometers, which enhance patient comfort and diagnostic accuracy. Increasing government initiatives for vision care programs, especially in developing nations, are expanding accessibility to tonometry. The rise in diabetes-related eye disorders, such as diabetic retinopathy and ocular hypertension, necessitates regular intraocular pressure monitoring. Growing investments in AI-integrated diagnostic tools are improving early disease detection. Expanding healthcare infrastructure in emerging economies and the increasing presence of specialized ophthalmic clinics contribute to market growth. Additionally, the surge in telemedicine and remote eye screening services is fostering market expansion by enabling early and widespread detection of ocular diseases.

The U.S. tonometer market is propelled by a strong regulatory framework ensuring product innovation and quality standards, leading to the adoption of FDA-approved advanced tonometry devices. The increasing prevalence of myopia and hyperopia among younger populations has heightened the demand for routine eye examinations. Strategic collaborations between ophthalmology device manufacturers and research institutions are driving technological enhancements. The rising popularity of portable and handheld tonometers supports use in home healthcare and ambulatory settings. Expanding insurance coverage for preventive eye care services encourages frequent screenings. Furthermore, the presence of leading ophthalmic equipment manufacturers and increasing investment in AI-driven tonometry solutions are accelerating market growth in the country. For instance, in May 2024, Reichert Technologies launched the Tono-Vera tonometer in the US, featuring the patented ActiView system for automated, reliable intraocular pressure (IOP) measurements. This handheld device uses rebound tonometry, eliminating the need for anesthetic. It provides quick, accurate readings, comparable to Goldmann tonometry, with user-friendly design and Bluetooth connectivity. Reichert, a leader in eye care diagnostics, continues its innovation with Tono-Vera, enhancing glaucoma patient care.

Tonometer Market Trends:

Integration of Artificial Intelligence in Tonometry

The incorporation of artificial intelligence (AI) in tonometry is transforming intraocular pressure (IOP) measurement by improving diagnostic accuracy and patient management. AI-powered tonometers utilize machine learning algorithms to analyze large datasets, enabling early detection of glaucoma and ocular hypertension. These devices can assess subtle variations in IOP that might be missed by conventional methods, allowing for more precise monitoring. AI integration also supports automated data interpretation, reducing dependence on specialist evaluations and enhancing accessibility in remote or underserved areas. Additionally, AI-enabled tonometers facilitate predictive analytics, identifying patients at risk for developing glaucoma before significant vision loss occurs. The growing focus on personalized medicine and digital health solutions is driving further advancements in AI-assisted tonometry, improving patient outcomes. For instance, in May 2024, Topcon Healthcare partnered with Microsoft to advance AI-driven "Healthcare from the Eye" solutions. They'll use cloud platforms for pre-screening systemic and neurological diseases via eye scans. Topcon's IDHea fosters AI research, ensuring data security. They're investing in AI innovators and using Microsoft Azure for secure data management. This aims to improve healthcare access, quality, and affordability through AI-powered eye diagnostics.

Rise of Non-Contact and Portable Tonometers

The increasing adoption of non-contact and portable tonometers is shaping the market by offering enhanced patient comfort and convenience. Non-contact tonometers (air-puff tonometers) eliminate the need for anesthesia, reducing discomfort and the risk of cross-contamination. These devices are particularly beneficial for pediatric and geriatric patients who may be sensitive to traditional tonometry techniques. For instance, in April 2023, Nidek released the NT-1/1e non-contact tonometers, omitting pachymetry to meet market needs. The NT-1 offers automated IOP measurements with patient safety features and voice guidance. The NT-1e provides manual measurement with 3D tracking. Both models feature a flexible, space-saving design for improved clinic efficiency and patient comfort. In parallel, handheld and portable tonometers are gaining popularity in home care settings, ambulatory centers, and teleophthalmology services, enabling remote monitoring and reducing the need for frequent clinical visits. The miniaturization of tonometry devices, combined with wireless connectivity and cloud-based data storage, allows real-time data sharing between healthcare providers and patients, facilitating continuous IOP monitoring and timely intervention in high-risk individuals.

Expansion of Teleophthalmology and Remote Eye Care Services

The rising demand for teleophthalmology and remote eye care solutions is significantly influencing the tonometer market. With increasing emphasis on accessible and cost-effective eye care, many healthcare providers are integrating tonometry into digital health platforms. Remote IOP measurement, enabled by connected tonometry devices and telemedicine applications, allows ophthalmologists to monitor patients without requiring frequent in-person consultations. This trend is particularly impactful in rural and underserved regions, where access to specialized ophthalmic care is limited. Additionally, the expansion of wearable tonometers capable of continuous IOP monitoring is enhancing early disease detection. For instance, in March 2024, the National Eye Institute granted USD 6.7 Million to Purdue University to develop innovative smart contact lens tonometers. These patent-pending devices, utilizing "StickTronics," will continuously monitor intraocular pressure (IOP) and deliver therapeutic drugs, aiding in the management of chronic eye conditions like glaucoma. Besides this, the shift toward virtual eye screenings and AI-powered diagnostics is expected to bridge the gap in glaucoma management, ensuring timely intervention and reducing the risk of vision impairment.

Tonometer Industry Segmentation:

Analysis by Type:

  • Direct
  • Indirect

Indirect stand as the largest type in 2024. The dominance of the indirect segment within the tonometer market is largely attributed to the increasing prevalence of glaucoma and the growing need for efficient and patient-friendly intraocular pressure (IOP) measurement. Indirect tonometers, particularly rebound tonometers, offer advantages such as reduced patient discomfort and a lower risk of corneal damage, making them suitable for widespread screening, including in pediatric and geriatric populations. Additionally, advancements in technology have improved the accuracy and reliability of indirect tonometers, further driving their adoption in clinical settings.

Analysis by Technology:

  • Applanation Tonometry
  • Indentation Tonometry
  • Rebound Tonometry
  • Others

Applanation tonometry leads the market with around 51.4% of market share in 2024. Applanation tonometry's dominance in the tonometer market stems from its established reliability and accuracy in measuring intraocular pressure (IOP), a crucial factor in glaucoma diagnosis. The Goldmann applanation tonometer, in particular, is considered the "gold standard" for IOP measurement, contributing to its widespread use in clinical settings. This technique's ability to provide consistent and precise readings has solidified its position, even with the emergence of newer technologies. Additionally, established clinical practices and widespread familiarity among ophthalmologists reinforce the continued preference for applanation tonometers.

Analysis by Portability:

  • Desktop
  • Handheld

Handheld leads the market with around 72.2% of market share in 2024. The dominance of the handheld tonometer segment in the market stems from its enhanced portability and convenience. These devices enable healthcare professionals to conduct intraocular pressure (IOP) measurements in various settings, beyond traditional clinic environments. This flexibility is crucial for screening programs, home healthcare, and situations where patient mobility is limited. Furthermore, advancements in technology have led to increased accuracy and ease of use in handheld tonometers, making them a preferred choice for both practitioners and patients. The growing prevalence of glaucoma and the rising geriatric population, who require frequent IOP monitoring, further fuel the demand for these portable devices

Analysis by End User:

  • Hospitals
  • Ophthalmic Centers

Ophthalmic centers lead the market with around 62.0% of market share in 2024. Ophthalmic centers dominate the tonometer market due to their specialized focus on eye care. These centers are primary locations for diagnosing and managing conditions like glaucoma, which necessitates frequent intraocular pressure (IOP) measurements. Therefore, they require a consistent and high volume of tonometer usage. Ophthalmic centers conduct routine screenings and detailed examinations, driving demand for both desktop and handheld tonometers. Additionally, these facilities often invest in advanced tonometer technology to ensure accurate and reliable IOP readings, contributing to their significant market share. The increase in eye related diseases, and an aging population, also increases the amount of patients visiting these centers.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 39.6%. North America's dominance in the tonometer market stems from a confluence of factors. Robust healthcare infrastructure, coupled with a high prevalence of eye disorders like glaucoma, drives significant demand. For instance, the CDC reports glaucoma affects about 3 million Americans and is the second leading cause of global blindness. Open-angle glaucoma, the most common type, often has no early symptoms, leaving 50% of those affected unaware, heightening the need for diagnostic tools like tonometer. The region's advanced medical technology adoption, particularly in the United States, fosters innovation and the development of sophisticated tonometers. Furthermore, the presence of key industry players and established healthcare centers reinforces market leadership. A large geriatric population, which is more prone to glaucoma, also contributes to the high demand for tonometers. All of these points add up to North America being the leading market for tonometers.

Key Regional Takeaways:

United States Tonometer Market Analysis

In 2024, the United States held 91.4% of the market share in North America. The growing adoption of tonometer due to the rising prevalence of eye-related disorders is a significant market driver. According to reports, about 1.8 Million Americans aged 40 years and older are affected by AMD. With increasing cases of glaucoma and other ocular conditions, the demand for tonometer devices has risen across various healthcare settings. Regular eye screenings have become crucial as early detection of eye-related disorders help in effective treatment. The rising awareness about eye health, along with advancements in diagnostic technologies, are further fueling the adoption of tonometer. Additionally, improved healthcare infrastructure and accessibility to ophthalmic care have supported market expansion. The integration of digital tonometer devices in hospitals and clinics has also contributed to market growth. Increased healthcare expenditure and government initiatives promoting eye health screenings have encouraged the use of tonometer across different age groups. The focus on patient-centric care, coupled with ongoing innovations in non-contact tonometer devices, has led to wider acceptance in medical facilities. The expanding network of optometrists and ophthalmologists further supports the growing tonometer adoption due to growing eye-related disorders.

Asia Pacific Tonometer Market Analysis

The escalating prevalence of glaucoma, projected to impact 27.8 million additional people in Asia by 2040, primarily in India and China, is fueling substantial tonometer demand. Rapid urbanization and lifestyle shifts increase glaucoma incidence, driving routine eye screenings. Enhanced healthcare infrastructure expands tonometer accessibility in facilities, while governmental initiatives promote early ocular disease detection. The growing number of eye care professionals further broadens access to advanced tonometer technologies. The need for convenient monitoring encourages the adoption of portable, user-friendly home tonometers. Continuous R&D efforts are yielding innovative tonometers with improved accuracy and efficiency, crucial for effective glaucoma management.

Europe Tonometer Market Analysis

The expanding elderly population is a primary catalyst for tonometer market growth, as age significantly elevates the risk of ocular diseases. WHO data highlights the European Region's aging trend, with projections of 300 million individuals aged 60+ by 2050. This demographic shift intensifies demand for tonometers, crucial for diagnosing conditions like glaucoma. Geriatric care facilities are increasingly equipped with these devices, enhancing early detection. Continued research fuels innovation in tonometer technology, resulting in more accurate and user-friendly devices, such as automated and digital models. This technological advancement allows for more efficient screening. Moreover, government investments in elderly healthcare, combined with heightened public awareness about proactive eye health, further propel tonometer adoption. Integrating tonometers into comprehensive ophthalmic care ensures timely intervention, preserving vision in the aging population.

Latin America Tonometer Market Analysis

The surging diabetic population in Latin America is significantly fueling tonometer device demand. With 31.6 million diabetics in 2019, projections indicate a rise to 40.2 million by 2030, and 49.1 million by 2045. This growth directly correlates with increased diabetic retinopathy and glaucoma cases, necessitating routine intraocular pressure monitoring. Healthcare providers are integrating tonometers into standard diabetes care, enhancing early detection. Expanding healthcare initiatives are improving tonometer accessibility in hospitals and diagnostic centers. The diabetic surge is also driving research into advanced tonometer technologies for improved diagnostic precision. Public health campaigns are crucial, educating individuals about the critical link between diabetes and eye health, thereby promoting proactive eye care.

Middle East and Africa Tonometer Market Analysis

The tonometer market is expanding due to the rapid growth of healthcare facilities, as evidenced by Dubai's sector, which saw a surge to 4,482 private medical facilities and 55,208 licensed professionals by 2022, with further growth projected. Increased healthcare infrastructure investments are enhancing access to advanced tonometers. Additionally, rising health awareness campaigns emphasizing preventive eye care, coupled with expanding ophthalmic diagnostic services, are driving routine tonometer screenings. This heightened focus on early detection is significantly contributing to market growth.

Competitive Landscape:

The tonometer market's competitive landscape is characterized by a mix of established medical device manufacturers and specialized ophthalmic technology companies. Innovation is a key driver, with firms focusing on developing more portable, user-friendly, and accurate tonometers. Competition centers on technological advancements, such as non-contact and rebound tonometry, and integrated devices with digital capabilities. Market players strive to offer comprehensive solutions, including data management and connectivity, to enhance clinical workflows. Price competition exists, particularly for basic models, while premium devices with advanced features command higher prices. Strategic partnerships and acquisitions are also common tactics to expand product portfolios and market reach. Regulatory approvals and adherence to stringent quality standards are critical for market entry and sustained growth.

The report provides a comprehensive analysis of the competitive landscape in the tonometer market with detailed profiles of all major companies, including:

  • 66 Vision Tech Co. Ltd. (Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.)
  • AMETEK Inc.
  • Canon Inc.
  • Haag-Streit Group (Metall Zug AG)
  • Keeler Ltd. (Halma plc)
  • Kowa American Corporation (Kowa Company Limited)
  • Nidek Co. Ltd.
  • Revenio Group Oyj
  • Rexxam Co. Ltd.
  • Tomey Corporation
  • Topcon Corporation
  • Ziemer Ophthalmic Systems AG

Key Questions Answered in This Report

  • 1.How big is the tonometer market?
  • 2.What is the future outlook of tonometer market?
  • 3.What are the key factors driving the tonometer market?
  • 4.Which region accounts for the largest tonometer market share?
  • 5.Which are the leading companies in the global tonometer market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tonometer Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Direct
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Indirect
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Applanation Tonometry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Indentation Tonometry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Rebound Tonometry
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Portability

  • 8.1 Desktop
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Handheld
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ophthalmic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 66 Vision Tech Co. Ltd. (Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.)
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 AMETEK Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 Canon Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Haag-Streit Group (Metall Zug AG)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Keeler Ltd. (Halma plc)
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Kowa American Corporation (Kowa Company Limited)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Nidek Co. Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Revenio Group Oyj
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Rexxam Co. Ltd.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Tomey Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 SWOT Analysis
    • 15.3.11 Topcon Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Ziemer Ophthalmic Systems AG
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제